Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres

2014 ◽  
Vol 101 (4) ◽  
pp. 440-440
Author(s):  
D. Civalleri ◽  
G. Scopinaro ◽  
N. Balletto ◽  
F. Claudiani ◽  
F. DeCian ◽  
...  
1989 ◽  
Vol 76 (7) ◽  
pp. 699-703 ◽  
Author(s):  
D. Civalleri ◽  
G. Scopinaro ◽  
N. Balletto ◽  
F. Claudiani ◽  
F. Decian ◽  
...  

1993 ◽  
Vol 29 (5) ◽  
pp. 1020 ◽  
Author(s):  
Tae Hoon Kim ◽  
Yup Yoon ◽  
Jae Hoon Lim ◽  
Young Tae Ko ◽  
Dong Ho Lee

2013 ◽  
Vol 32 (9) ◽  
pp. 954-958
Author(s):  
Dong-juan XING ◽  
Wei-hua SONG ◽  
Shao-juan GONG ◽  
Ai-min XU ◽  
Xiao-wei LI ◽  
...  

2011 ◽  
Vol 70 (5) ◽  
pp. 1032-1037 ◽  
Author(s):  
Christian Letoublon ◽  
Irene Morra ◽  
Yao Chen ◽  
Valerie Monnin ◽  
David Voirin ◽  
...  

1988 ◽  
Vol 67 (12) ◽  
pp. 1142???1148 ◽  
Author(s):  
H. Ahlman ◽  
L. ??hlund ◽  
A. Dahlstr??m ◽  
J. Martner ◽  
O. Stenqvist ◽  
...  

2018 ◽  
Vol 31 (05) ◽  
pp. 301-308 ◽  
Author(s):  
Raphael Byrne ◽  
Rodney Pommier

AbstractNeuroendocrine tumors, or carcinoid tumors, of both the midgut and hindgut are quite rare, but their incidence is increasing. Surgery is the treatment of choice in patients who can tolerate an operation and have operable disease. Options for the treatment of metastatic disease include cytoreductive surgery, somatostatin analogues, interferon α, local liver therapies (hepatic arterial embolization, ablation), chemotherapy, Peptide-Receptor Radionucleotide Radiotherapy, angiogenesis inhibitors, and mammalian target of rapamycin inhibitors.


Sign in / Sign up

Export Citation Format

Share Document